FLIR Nabs Small DTRA Award to Further Develop Stand-off Rad Detection System

June 2011
TR2: Terror Response Technology Report;6/22/2011, Vol. 7 Issue 13, p3
Trade Publication
The article reports on the contract awarded to FLIR Systems, Inc. by the U.S. Defense Threat Reduction Agency (DTRA). The agreement would cover the second phase of a multi-year, research and development program for a stand-off radiation detection system with identification capabilities and a mobile, ruggedized structure. The nine-month phase two will concentrate on reducing voxel size and delivering a two-voxel by two-voxel arrangement for laboratory demonstration.


Related Articles

  • Defense Threat Reduction Agency Awards FLIR Systems Stand-off Radiation Detection System Contract.  // Military Technology;2011, Vol. 35 Issue 8, p13 

    The article reports that the FLIR Systems Inc. has secured a 1.1 million dollars contract from the U.S. Defense Threat Reduction Agency for the Phase II development of an advanced stand-off radiation detection system.

  • DTRA Seeks Comprehensive National Incident Management System.  // TR2: Terror Response Technology Report;8/4/2010, Vol. 6 Issue 16, p21 

    The article deals with the Sources Sought notice issued by the U.S. Defense Threat Reduction Agency (DTRA) in relation to its requirement to build upon an existing experimental research and development computing platform and prototype for a system capability that provides detail and performance...

  • Invitrogen completes development of biothreat detection device.  // Diagnostics & Imaging Week;7/19/2007, Vol. 10 Issue 29, p7 

    This article reports on the completion by Invitrogen Federal Systems, a unit of Invitrogen, of the development of a prototype handheld device for the detection of multiple biothreat agents in a single sample under a $3.9 million contract from the U.S. Defense Threat Reduction Agency. It explains...

  • IntegenX Nabs Potential $15M for Pathogen Detection, Identification System.  // TR2: Terror Response Technology Report;10/13/2010, Vol. 6 Issue 21, p13 

    This article focuses on the contract awarded to IntegenX Inc. by the U.S. Defense Threat Reduction Agency to develop an integrated sample-to-sequence system for rapid detection and identification of genetically engineered bacterial and viruses, medically relevant bacteria and viruses, and...

  • TASC Awarded $97 Million IDIQ To Support DTRA.  // Defense Daily;3/22/2011, Vol. 249 Issue 54, p4 

    The article presents information on a contract awarded to TASC Inc. by the U.S. Defense Threat Reduction Agency (DTRA). The contract deals in providing advisory and assistance services to the Combat Support and Nuclear Support Directorates of the DTRA Operations Enterprise. TASC will support...

  • ICx Technologies [ICXT]: DTRA Awards ICx $9.1M to Participate in Two Advanced Tech Demos.  // TR2: Terror Response Technology Report;6/23/2010, Vol. 6 Issue 13, p14 

    The article reports on two contracts worth 9.1 million U.S. dollars awarded to ICx Technologies (ICXT) by the U.S. Defense Threat Reduction Agency (DTRA) to participate in two separate Advanced Technology Demonstrations.

  • Peregrine Nicked By Budget Cuts To Defense Programs. Young, Donna // BioWorld Today;12/18/2007, Vol. 18 Issue 244, p1 

    The article reports on the decision of the U.S. Department of Defense to halt negotiations with Peregrine Pharmaceuticals Inc. for the finalization of a contract with the Defense Threat Reduction Agency. The contract involved a proposal to investigate Peregrine's monoclonal antibody bavituximab...

  • OSI Geospatial Wins $3.8M Defense Contract.  // GPS World;Nov2006, Vol. 17 Issue 11, p24 

    The article reports on the $3.8 million contract received by the OSI Geospatial Inc. from the U.S. Defense Threat Reduction Agency (DTRA) in the U.S. The contract involves the development of a Global Positioning System Denied Navigation and Mapping System for the DTRA. The DTRA has been a new...

  • Trius Lands $29.5M DoD Antibiotic Contract.  // Bioworld Week;5/24/2010, Vol. 18 Issue 21, p5 

    The article reports on the 29.5 million U.S. dollars four-and-a-half-year contract received by Trius Therapeutics Inc. from the Department of Defense's Defense Threat Reduction Agency for the development new antibiotics against gram-negative bacterial pathogens, such as Yersinia pestis,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics